Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

CaArray_topal-00039: TCGA (GBM): MicroRNA Analysis of TCGA GBM samples using Agilent MicroRNA array (UNC)

ABSTRACT: MicroRNA Analysis of TCGA GBM samples using Agilent MicroRNA array

ORGANISM(S): Homo sapiens

PROVIDER: GSE91014 | GEO | 2016/12/09

SECONDARY ACCESSION(S): PRJNA356720

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

caArray_topal-00242: MicroRNA Analysis of TCGA Ovarian samples using Agilent MicroRNA array

Project description:MicroRNA Analysis of TCGA OVA samples using Agilent MicroRNA array

2016-12-22 | GSE92683 | GEO

caArray_EXP-576: TCGA (LUAD): Gene Expression Analysis of TCGA samples using Agilent Expression 244K microarrays (UNC)

Project description:Gene Expression Analysis of TCGA samples using Agilent Expression 244K microarrays.

2015-05-13 | GSE68787 | GEO

caArray_EXP-574: TCGA(Kirc): Gene Expression Analysis of TCGA samples using Agilent Expression 244K microarrays (UNC)

Project description:Gene Expression Analysis of TCGA samples using Agilent Expression 244K microarrays.

2015-05-13 | GSE68784 | GEO

caArray_EXP-576: TCGA (LUAD): Gene Expression Analysis of TCGA samples using Agilent Expression 244K microarrays (UNC)

Project description:Gene Expression Analysis of TCGA samples using Agilent Expression 244K microarrays. EXP-576 Assay Type: Gene Expression Provider: Agilent Array Designs: AgilentG4502A_07_3 Organism: Homo sapiens (ncbitax) Tissue Sites: Lung Material Types: Control Analyte, organism_part, Primary solid_tumor, genomic_DNA Disease States: Lung Adenocarcinoma, NOT SPECIFIED

2015-05-13 | E-GEOD-68787 | biostudies-arrayexpress

caArray_EXP-574: TCGA(Kirc): Gene Expression Analysis of TCGA samples using Agilent Expression 244K microarrays (UNC)

Project description:Gene Expression Analysis of TCGA samples using Agilent Expression 244K microarrays. EXP-574 Assay Type: Gene Expression Provider: Agilent Array Designs: AgilentG4502A_07_3 Organism: Homo sapiens (ncbitax) Tissue Sites: Kidney Material Types: Control Analyte, organism_part, Primary solid_tumor, genomic_DNA Disease States: Kidney Clear Cell Renal Carcinoma, NOT SPECIFIED

2015-05-13 | E-GEOD-68784 | biostudies-arrayexpress

Homo sapiens

Project description:caArray_topal-00039: TCGA (GBM): MicroRNA Analysis of TCGA GBM samples using Agilent MicroRNA array (UNC)

| PRJNA356720 | ENA

caArray_laird-00051: TCGA Analysis of DNA Methylation for GBM Using Illumina Golden Gate BeadArray platform

Project description:TCGA Analysis of DNA Methylation for GBM Using Illumina Golden Gate BeadArray platform

2015-11-21 | GSE75244 | GEO

caArray_laird-00098: TCGA Analysis of DNA Methylation for GBM Using Illumina Golden Gate BeadArray platform (IlluminaDNAMethylation_OMA003_CPI)

Project description:TCGA Analysis of DNA Methylation for GBM Using Illumina Golden Gate BeadArray platform

2015-11-21 | GSE75254 | GEO

caArray_socci-00214: TCGA Analysis of Copy Number for OV Using Agilent Human Genome CGH Microarray Kit 244K

Project description:TCGA Analysis of Copy Number for OV Using Agilent Human Genome CGH Microarray Kit 244K

2016-12-07 | GSE90928 | GEO

The Cancer Genome Atlas (TCGA) Consortium Integrated DNA Methylation Analysis

Project description:Aberrant hypermethylation of CpG dinucleotides located in CpG islands within the promoters of key cancer genes is an epigenetic abnormality associated with heritable transcriptional gene silencing and inactivation in cancer. The genes involved include important tumor suppressors affecting key pathways for tumor initiation and progression. These methylated sequences can serve as potentially valuable markers for cancer risk assessment, diagnosis, prognosis, and prediction of therapeutic responses. In addition, many key cancer genes may be targeted by both epigenetic and genetic alterations and, thus epigenetic analysis can help focus the search for mutations, and vice versa. Studies of major cancer types suggest that any individual patient’s tumor may harbor at least 300 or more DNA hypermethylated genes. In TCGA, a pilot project is underway to begin defining these genes for GBM via genomic approaches. The approach in the epigenetic pilot is a two-tiered one which, first, involves pharmacological treatment of both well established human GBM cell lines, and a cell line grown as a neurosphere to enrich for tumor propagating cells, with a DNA methylation inhibitor (5-aza-2’-deoxycytidine, DAC) or a histone deacetylation inhibitor (trichostatin A) followed by an expression transcriptome analysis as previously described (Schuebel et. al.). This has resulted in identification of more than 3,700 total candidate genes. In the second tier, the top candidates are then analyzed on a custom Illumina GoldenGate array with the capacity to monitor methylation at a single CpG dinucleotide in the CpG islands of 1,498 gene promoters for the high throughput analysis of TCGA GBM samples. Keywords: Microarray, Hypermethylome, DNA-hypermethylation, DAC, TSA, Epigenetic, TCGA, The Cancer Genome Atlas, GBM, Glioblastoma, Glioblastoma multiforme, Brain

2009-01-01 | GSE11233 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data